Somatostatin Receptor Positive (SSTR+) research hub

Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET

This study looks at a new treatment for certain types of advanced bowel and pancreatic cancers (GEP-NETs). It compares a combination of a new drug ([177Lu]Lu-DOTA-TATE) and an existing one (Octreotide LAR) to Octreotide LAR alone, checking how well it works and if it's safe.